skip to main content
Results 1 2 3 4 5 next page
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100
Material Type:
Newsletter Articles
Add to e-Shelf

10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100

Health & Medicine Week, 2004

NewsRX LLC

Full text available

2
10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100
Material Type:
Newsletter Articles
Add to e-Shelf

10-Year survival of PCL-substituting TKA in young rheumatoid patients nears 100

Biotech Week, 2004, p.390

NewsRX LLC

Full text available

3
2009 Medco drug trend report
Material Type:
Newsletter Articles
Add to e-Shelf

2009 Medco drug trend report

Medical Benefits, 2009, Vol.26 (11), p.1

New York: Aspen Publishers, Inc

Full text available

4
Aadalimumab significantly improves signs and symptoms of joint disease
Material Type:
Newsletter Articles
Add to e-Shelf

Aadalimumab significantly improves signs and symptoms of joint disease

Health & Medicine Week, 2004, p.759

NewsRX LLC

Full text available

5
Aadalimumab significantly improves signs and symptoms of joint disease
Material Type:
Newsletter Articles
Add to e-Shelf

Aadalimumab significantly improves signs and symptoms of joint disease

Biotech Week, 2004, p.17

NewsRX LLC

Full text available

6
Aadalimumab significantly improves signs and symptoms of joint disease
Material Type:
Newsletter Articles
Add to e-Shelf

Aadalimumab significantly improves signs and symptoms of joint disease

Pharma Business Week, 2004, p.207

NewsRX LLC

Full text available

7
Aarhus University; One step closer to tailored treatment of severe rheumatic diseases
Material Type:
Newsletter Articles
Add to e-Shelf

Aarhus University; One step closer to tailored treatment of severe rheumatic diseases

NewsRx Health & Science, 2020, p.409

Atlanta: NewsRx

Full text available

8
AAV-based treatment completely suppresses rheumatoid arthritis in animal models
Material Type:
Newsletter Articles
Add to e-Shelf

AAV-based treatment completely suppresses rheumatoid arthritis in animal models

Pharma Business Week, 2004, p.187

NewsRX LLC

Full text available

9
AAV-based treatment completely suppresses rheumatoid arthritis in animal models
Material Type:
Newsletter Articles
Add to e-Shelf

AAV-based treatment completely suppresses rheumatoid arthritis in animal models

Health & Medicine Week, 2004, p.920

NewsRX LLC

Full text available

10
AbbVie; AbbVie Presents New Data at the European E-Congress of Rheumatology EULAR 2020 Showcasing Depth of its Rheumatology Portfolio
Material Type:
Newsletter Articles
Add to e-Shelf

AbbVie; AbbVie Presents New Data at the European E-Congress of Rheumatology EULAR 2020 Showcasing Depth of its Rheumatology Portfolio

Pharma Business Week, 2020, p.8

Atlanta: NewsRx

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Creation Date 

From To
  1. Before2004  (335)
  2. 2004To2007  (531)
  3. 2008To2011  (88)
  4. 2012To2016  (814)
  5. After 2016  (4,002)
  6. More options open sub menu

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far